Sub-Saharan Africa might not be considered among the top destinations for the global pharmaceutical industry, but Shalina Healthcare considers it home and has established itself as the leading pharma company in the region. Co-CEOs and siblings, Shalina Clifford and Abbas Virji, walk us through the company’s 35-year history of commitment to the region, bringing innovative and necessary medicine to overlooked markets. Furthermore, they outline their ambitious strategy to establish manufacturing capabilities in the continent and add more therapeutic areas to the portfolio in order to consolidate the Shalina brand as a synonym of Sub-Saharan healthcare.
Sub-Saharan Africa has huge potential, with the population expected to increase by more than one billion by 2050.
